Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Hepatology (Baltimore, Md.)|November 3, 2011
Retreatment with telaprevir combination therapy in hepatitis C patients with well-characterized prior treatment responseAndrew J Muir, Fred F Poordad, John G McHutchison, et al.
The New England Journal of Medicine|May 1, 2009
Telaprevir and peginterferon with or without ribavirin for chronic HCV infectionChristophe Hézode, Nicole Forestier, Geoffrey Dusheiko, et al.
JHEP Reports : Innovation in Hepatology|August 9, 2023
Enhancing interventions for prevention of mother-to-child- transmission of hepatitis B virusPhilippa C Matthews, Ponsiano Ocama, Su Wang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 4, 2014
Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml)Scott Fung, Stuart C Gordon, Zahary Krastev, et al.
The Lancet. Gastroenterology & Hepatology|July 10, 2022
Treatment of hepatocellular carcinoma in sub-Saharan Africa: challenges and solutionsEduard Jonas, Marc Bernon, Barbara Robertson, et al.
Scientific Reports|May 6, 2016
Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis BHai Li, Liu-Ying Chen, Nan-Nan Zhang, et al.
The Lancet. Gastroenterology & Hepatology|November 15, 2017
Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030Mark W Sonderup, Mary Afihene, Reidwaan Ally, et al.
The Lancet. Gastroenterology & Hepatology|November 15, 2017
Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targetsC Wendy Spearman, Mary Afihene, Reidwaan Ally, et al.
The Lancet. Gastroenterology & Hepatology|July 10, 2022
Hepatocellular carcinoma: measures to improve the outlook in sub-Saharan AfricaC Wendy Spearman, Geoffrey Dusheiko, Eduard Jonas, et al.
The Journal of Infection|August 22, 2025
Evaluation of Hepatitis B core-related antigen (HBcrAg) as a biomarker in cohorts from the United Kingdom and South AfricaLouise O Downs, Marion Delphin, Marije van Schalkwyk, et al.
Pageof 14